PAVmed Inc. (PAVM)
NASDAQ: PAVM · Real-Time Price · USD
0.4856
+0.0359 (7.98%)
At close: Oct 7, 2025, 4:00 PM EDT
0.5199
+0.0343 (7.06%)
Pre-market: Oct 8, 2025, 4:14 AM EDT
PAVmed Market Cap
PAVmed has a market cap or net worth of $10.32 million as of October 7, 2025. Its market cap has decreased by -38.58% in one year.
Market Cap
10.32M
Enterprise Value
15.25M
1-Year Change
-38.58%
Ranking
Category
Stock Price
$0.49
Market Cap Chart
Since July 28, 2016, PAVmed's market cap has decreased from $173.00M to $10.32M, a decrease of -94.04%. That is a compound annual growth rate of -26.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 10.70M | 55.07% |
| Dec 31, 2024 | 6.90M | -79.22% |
| Dec 29, 2023 | 33.20M | -26.22% |
| Dec 30, 2022 | 45.00M | -79.20% |
| Dec 31, 2021 | 216.30M | 95.22% |
| Dec 31, 2020 | 110.80M | 151.25% |
| Dec 31, 2019 | 44.10M | 72.94% |
| Dec 31, 2018 | 25.50M | -19.56% |
| Dec 29, 2017 | 31.70M | -65.47% |
| Dec 30, 2016 | 91.80M | -46.94% |
| Jul 28, 2016 | 173.00M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 758.63B |
| Johnson & Johnson | 453.15B |
| AbbVie | 406.64B |
| UnitedHealth Group | 324.93B |
| Novo Nordisk | 269.41B |
| AstraZeneca | 265.89B |
| Novartis AG | 257.47B |
| Abbott Laboratories | 232.77B |